Pediatric Clinical Trials

Pediatric Research

DivisionPISponsorTitle
Endocrinology Tollefsen Genentech, Inc. PMS II Study
Dermatology Siegfried Amgen Evaluate Safety of Etranercept in Pediatric Patients with Plaque Psoriasis
Pulmonary Noyes Seattle Children's Hospital EPIC Observational Study
Hematology Ferguson Fletcher Allen Phase II Research Study of Nifurtimox
Dermatology Siegfried Pierre Fabre Infantile Hemangiomas Study
Endocrinology Tollefsen Eli Lilly The Genetics and Neuroenocrinology of Short Stature International Study
Hematology Puetz Biogen Idec Inc. An Open-Label, Multicenter Evaluation of Safety, BIIB031
Hematology Ferguson Van Andel Institute NMRTC001
Pulmonary Paruthi UCB Biosciences SP1004 Study Restless Leg Syndrome
Pulmonary Paruthi UCB Biosciences SP1005 Study Restless Leg Syndrome
Hematology Ferguson University of Vermont A Phase1 Trial of TPI 287
Genetics Braddock University of California San Diego OTIS Autoimmune Diseases in Pregnancy Project
Pulmonary Wooldridge Cystic Fibrosis Foundation Therapeutics Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy
Gastro Teckman Genentech, Inc. A phase IIIb parallel group, open label study of pegylated interferon
Pulmonary Albers Hologic A Multi-Center Cystic Fibrosis Blood Sample Collection Study
Pulmonary Albers Kalobios Pharmaceuticals Study of KB001 A in Subjects with Cystic Fibrosis Infected with Pseudomonas aeruginosa
Hematology Ferguson Children's Hospital of Philadelphia COG industry Work Order
Pulmonary Albers Gilead Sciences Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas in Subjects with Cystic Fibrosis
Pulmonary Wooldridge Vertex Pharmaceuticals Efficacy and Safety of Lumacaftor Monotherapy in Subjects Aged 12 Years and Older with Cystic Fibrosis
Hematology Ferguson Children's Hospital of Philadelphia A Phase I/II Trial of TPI 287 in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma NMTRC004
Allergy Knutsen Baxter Healthcare Corp Safety, Tolerability, and Pharmacokinetics in Subjects with Primary Immunodeficiency Diseases
Hematology Puetz Biogen Idec Inc. Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A
Hematology Ferguson Janssen Research Foundation Abciximab (ReoProR) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Pulmonary Wooldridge Vertex Pharmaceuticals Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis
Hematology Ferguson Spectrum Health Hospitals NMTRC 008 A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients
Hematology Ferguson Eli Lilly Prasugrel and Placebo in Pediatric Patients with Sickle Cell Disease
Hematology Ferguson Van Andel Institute Neuroblastoma in Remission - Protocol Number NMTRC 003
Pulmonary Albers Novartis Pharmaceuticals Tobramycin Inhalation Powder (TIP) administered once daily in patients with cystic fibrosis
Hematology Puetz American Thrombosis and Hemostasis Network My Life, Our Future: A Hemophilia Genotyping Initiative Data and Sample Registry Repository
Hematology Ferguson Children's Hospital of Philadelphia COG Industry Work Order: FP17305 SUB102 02 GLENNON SANOFI AALL1131 WO
Gastro Teckman Alnylam - Alpha 1 Natural History Study
Gastro Teckman Gilead Sciences Gilead US 334-1112
Nephrology Wood Amgen Cincalcet HCI in Pediatrics
Hematology Ferguson Van Andel Institute NMTRC 009 Molecular Guided therapy for the treatment of refractory cancers
Hematology Puetz Biogen Idec Inc. Biogen 998HB303
Endocrinology Siska Novo Nordisk Novo Nordisk - NN2211-3659 Ellipse
Allergy Knutsen Hoffman LaRoche Acoustics - WB28182
Endocrinology Myers Zafgen Zafgen ZAF 311 Trial of ZGN 440 Beloranib
Gastro Teckman Gilead Sciences Gilead US 334-1116 Ledipasvir/Sofosbuvir tx for Hep C in Children
Hematology Puetz Biogen Idec Inc. PUP Hemophilia A
Higher purpose. Greater good.
© 1818 - 2017  SAINT LOUIS UNIVERSITY   |   Disclaimer   |  Mobile Site
St. Louis   |   Madrid